Bristol-Myers and Starboard Value spar over $74B Celgene buyout as shareholder vote looms

Bristol-Myers and Starboard Value spar over $74B Celgene buyout as shareholder vote looms

Source: 
Endpoints
snippet: 

Bristol-Myers Squibb execs and Starboard Value are back at it today, exchanging broadsides for and against the $74 billion buyout.